New schizophrenia drug shows promise in long-term trial
NCT ID NCT01625897
First seen Jan 07, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study looked at the long-term safety and effectiveness of a drug called MP-214 in 125 people with chronic schizophrenia or elderly patients. The main goal was to track any side effects and see how well the drug worked over time. The results help doctors understand if MP-214 is a safe option for managing schizophrenia symptoms long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Aizu-Wakamatsu, Fukushima, Japan
Conditions
Explore the condition pages connected to this study.